Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-15T00:37:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for inquiries about joining the study and includes a reference to the Contacts and Locations section in the How to Read a Study Record.
    Difference
    2%
    Check dated 2024-12-07T22:04:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, lung cancer, and clinical studies have been removed, indicating a potential shift in focus or resource availability.
    Difference
    3%
    Check dated 2024-11-23T05:57:48.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources related to lung cancer, including links to MedlinePlus and PubMed, as well as new data fields for study information.
    Difference
    3%
    Check dated 2024-11-08T19:04:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.0%
    Check dated 2024-11-01T11:37:30.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T01:27:00.000Z thumbnail image

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.